... Administration (FDA) has consequently re-classified the polypropylene mesh as a high-risk device. Therefore, the need for new meshes to cure POP with a rapid prototyping technique is urgent, especially for personalized medicine. Therefore, we developed a new implantable mesh using biocompatible polymers (e.g...